WeVote
Log In

Bill

Bill

S 3576

Establishes the statewide fibroid study program and statewide fibroid study program fund

2025 Regular Session Introduced by Cordell Cleare and 1 co-sponsor

Establishes a statewide fibroid study program and a dedicated fund to finance research, data collection, and education to improve understanding and care.

REPORTED AND COMMITTED TO FINANCE
0
WeVote Research Nonpartisan
Bill Summary · S 3576

Summary: S 3576 – Establishes the statewide fibroid study program and statewide fibroid study program fund

Overview

S 3576 proposes creating a dedicated statewide fibroid study program and a corresponding fund to support that program. Introduced January 28, 2025, the bill is currently advancing through committee consideration, having been referred to Women’s Issues and later reported and committed to Finance. The bill has both Senate sponsors (primary: Cordell Cleare; cosponsor: Lea Webb) and related companion bills in other chambers.

Purpose and Intent

  • Create a formal state-level framework to study fibroids, including prevalence, risk factors, outcomes, and potential impacts on health disparities.
  • Establish a dedicated fund (the statewide fibroid study program fund) to support the program’s activities, research, education, and related initiatives.
  • Position the state to collect data, support researchers and healthcare providers, and inform public health strategies related to fibroids.

Key Provisions (as introduced)

  • Establishment of a statewide fibroid study program to centralize research, data collection, and educational efforts related to fibroids.
  • Creation of a dedicated fund, the statewide fibroid study program fund, to finance program activities.
  • The bill would define governance, administrative oversight, and funding mechanisms (specifics to be set forth in the enacted text).
  • Likely components (typical for such programs) may include research grants, stipends for data collection efforts, public health outreach, and reporting requirements, though exact provisions require reading the full text.
  • The text suggests support for coordination with other related efforts or companion bills in the legislature (see Related Legislation).

Administration and Funding

  • Administered under state health or public health authorities per eventual bill language.
  • Funding would come from the newly created statewide fibroid study program fund; specifics on appropriation sources and annual funding levels would be determined in the final bill and subsequent budget processes.
  • Oversight and reporting requirements would be defined in the enacted law (e.g., annual reports, performance metrics, and accountability measures).

Affected Parties

  • Individuals with fibroids and patient communities (focus on enhanced study, data, and potential public health benefits).
  • Healthcare providers and researchers conducting fibroid-related studies.
  • State agencies (likely the Department of Health or equivalent) responsible for program administration.
  • Academic institutions and health systems that may participate in research and data collection.
  • General public through outreach and education initiatives.

Procedural History and Timeline

  • Introduced: January 28, 2025.
  • Legislative actions: Referred to Women’s Issues (Jan 28, 2025); subsequently reported and committed to Finance (Mar 11, 2025).
  • Status indicates movement toward potential floor consideration pending Finance committee action and further legislative steps.
  • Related legislation includes S 8574 and S 3221 (prior-session), with A 5412 as a companion measure in the Assembly.

Related Legislation

  • S 8574 (prior-session)
  • S 3221 (prior-session)
  • A 5412 (companion in the Assembly)

Potential Impact and Considerations

  • A formal study program and dedicated fund could improve understanding of fibroids, support targeted interventions, and address disparities in care.
  • The effectiveness will depend on enacted provisions detailing funding levels, governance, data privacy, collaboration with clinical partners, and concrete reporting requirements.
  • Monitoring of budgetary commitments and alignment with public health priorities will be important as the measure moves through the legislative process.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.